3M+ US users monthly for obesity drugs face concerns over significant weight regain upon stopping medication, as studies show.

3M+ US prescriptions monthly for obesity drugs like Wegovy, Ozempic, Mounjaro, and Zepbound raise concerns about what happens if users stop taking them. Studies show significant weight regain when pausing these drugs. Some users experiment with DIY methods to wean off the medication, but many don't stick with it, with a study finding only 40% of patients filling prescriptions continue use.